4366 Michel Ange
5 articles with Cyclenium Pharma
AiCuris Anti-infective Cures GmbH and Cyclenium Pharma Inc. announced today the signing of a collaboration agreement focused on finding new pharmaceutical compounds for the treatment and prevention of bacterial and viral diseases.
Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.
Cyclenium will receive an upfront payment and research funding from Ono, as well as development milestones and royalties on marketed products.
Cyclenium Announces A Research Collaboration With Hospital For Sick Children To Identify Novel Macrocyclic Modulators For Pharmacological Targets In Multiple Therapeutic Areas